| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/14/2002 | WO2001032695A3 MODULATION OF eNOS ACTIVITY AND THERAPEUTIC USES THEREOF |
| 02/14/2002 | WO2000073337A9 Polymer conjugates of hedgehog proteins and uses |
| 02/14/2002 | WO1997020938A3 Cells with hybrid receptor and gene construct which can be controlled by said hybrid receptor, and use of said cells in gene therapy |
| 02/14/2002 | US20020019517 Fibronectins for use as diagnostic and treatment tools in gene therapy |
| 02/14/2002 | US20020019515 Novel spoIIIE |
| 02/14/2002 | US20020019514 Nucleotide sequences coding fusion protein for use in the detection and treatment of diabetes, autoimmune disease and arthritis |
| 02/14/2002 | US20020019345 Administering to a patient having implant an effective amount of antagonist of CCR5 (chemokine receptor 5) function, to inhibit graft rejection, antagonist selected from small organic molecules, peptides, proteins, peptidomimetics |
| 02/14/2002 | US20020019341 Modulation of systemic memory T cell trafficking |
| 02/14/2002 | US20020019052 FACS assisted methods for introducing individual chromosomes into cells |
| 02/14/2002 | US20020019036 Antihemophilic protein; for use in diagnosis and treatment of autoimmune diseases and blood disorders |
| 02/14/2002 | US20020019029 Protein; for use in the treatment of cancer, cardiovascular disorders and nervous system disorders |
| 02/14/2002 | US20020019028 Peptide; for use in the treatment of defects associated with polypeptide transfer |
| 02/14/2002 | US20020019000 Polynucleotides coexpressed with matrix-remodeling genes |
| 02/14/2002 | US20020018995 Detecting brain disorders; obtain sample tissue, monitor tau mutant isoform duplications in cell, compare to wild type, amplification in tau mutant isoforms indicates brain disorders |
| 02/14/2002 | US20020018990 Reagents and methods useful for detecting diseases of the breast |
| 02/14/2002 | US20020018808 Vaccines against sterols |
| 02/14/2002 | US20020018783 Genetic engineering |
| 02/14/2002 | US20020018782 Binding to antibodies; prophylaxis, therapy of infections |
| 02/14/2002 | US20020018779 Non-anaphylactic forms of allergens and their use |
| 02/14/2002 | US20020018777 Deactivation using solvent and adsorber |
| 02/14/2002 | US20020018776 Method of treating graft rejection using inhibitors of CXCR3 function |
| 02/14/2002 | US20020018775 Complexing; separation; gene therapy |
| 02/14/2002 | US20020018766 Genes differentially expressed in cancer cells to design cancer vaccines |
| 02/14/2002 | US20020018751 Cellular and serum protein anchors for diagnostic imaging |
| 02/14/2002 | US20020018750 Anticancer agents |
| 02/14/2002 | US20020018749 High avidity polyvalent and polyspecific reagents |
| 02/14/2002 | DE10131425A1 Extracting immunoglobulin Y from egg yolk, useful as diagnostic or therapeutic antibodies, by dilution in water, is simple and provides high yields |
| 02/14/2002 | CA2820132A1 2,5-dkg permeases |
| 02/14/2002 | CA2634294A1 Production of humanized antibodies in transgenic animals |
| 02/14/2002 | CA2423519A1 A new slit-like protein obtained from a cdna library from hs-5 stromal cell line |
| 02/14/2002 | CA2422155A1 Production of humanized antibodies in transgenic animals |
| 02/14/2002 | CA2418952A1 A novel member of the lysyl oxidase gene family |
| 02/14/2002 | CA2418950A1 Soluble zcytor 11 cytokine receptors |
| 02/14/2002 | CA2418834A1 Iapl-3 a protein inhibitor of apoptosis proteins |
| 02/14/2002 | CA2418779A1 Schizophrenia related gene and protein |
| 02/14/2002 | CA2418445A1 Stress proteins and peptides and methods of use thereof |
| 02/14/2002 | CA2418144A1 Urocortin proteins and uses thereof |
| 02/14/2002 | CA2418014A1 Immunotherapy for chronic myelocytic leukemia |
| 02/14/2002 | CA2417970A1 2,5-dkg permeases |
| 02/14/2002 | CA2417969A1 Enhancement of industrial production by increasing substrate transport |
| 02/14/2002 | CA2417802A1 Ampk-related serine/threonine kinase, designated snark |
| 02/14/2002 | CA2417769A1 Drug metabolizing enzymes |
| 02/14/2002 | CA2417707A1 Sid.rtm. nucleic acids and polypeptides selected from a pathogenic strain of hepatitis c virus and applications thereof |
| 02/14/2002 | CA2417676A1 Sequences for integrin alpha-8 |
| 02/14/2002 | CA2417587A1 Transporters and ion channels |
| 02/14/2002 | CA2417368A1 Suppressor gene |
| 02/14/2002 | CA2417310A1 Iron regulating protein-2 (irp-2) as a diagnostic for neurodegenerative disease |
| 02/14/2002 | CA2416890A1 Therapeutic anti-melanoma compounds |
| 02/14/2002 | CA2406961A1 Cd40 antagonists for use in treating psoriasis and other inflammatory skin conditions |
| 02/13/2002 | EP1179592A1 Proteins nectin-3 |
| 02/13/2002 | EP1179591A1 Sodium ion-driven chloride/bicarbonate exchanger |
| 02/13/2002 | EP1179542A1 A ligand capable of binding to the adenosine deaminase binding-site of CD26 |
| 02/13/2002 | EP1179541A1 Compositions and methods for cancer treatment by selectively inhibiting VEGF |
| 02/13/2002 | EP1179540A1 Novel polypeptide |
| 02/13/2002 | EP1179539A1 Novel protein having hemolytic activity and gene encoding the protein |
| 02/13/2002 | EP1179348A2 Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases |
| 02/13/2002 | EP1179179A1 Use of an antibody to detect basophiles and/or mast cells |
| 02/13/2002 | EP1179070A2 Ers-genes, method of screening for chemical compounds capable of inducing ers in plants |
| 02/13/2002 | EP1179067A1 Neuroprotective properties of gdf-15, a novel member of the tgf-beta superfamily |
| 02/13/2002 | EP1179066A2 Extracellular signaling molecules |
| 02/13/2002 | EP1179065A2 Full-length molecules expressed in human tissues |
| 02/13/2002 | EP1179064A2 Secreted polypeptides and corresponding polynucleotides |
| 02/13/2002 | EP1179052A2 Serine proteases |
| 02/13/2002 | EP1179022A2 Bufornin 1 as a specific inhibitor and therapeutic agent for botulinum toxin b and tetanus neurotoxins |
| 02/13/2002 | EP1179019A2 Immunogenic peptides derived from mage and the use thereof |
| 02/13/2002 | EP1179016A1 Parasite antigens |
| 02/13/2002 | EP1179015A1 Dna molecules encoding human clax proteins and their soluble fusion proteins |
| 02/13/2002 | EP1179013A1 Protein scaffold and its use to multimerise monomeric polypeptides |
| 02/13/2002 | EP1179010A2 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins |
| 02/13/2002 | EP1179007A1 Self-assembling biomolecular structures |
| 02/13/2002 | EP1179002A1 Methods using mechanisms of action of aroa |
| 02/13/2002 | EP1178829A1 Human monoclonal antibody |
| 02/13/2002 | EP1178828A1 Death domain containing receptor 4 |
| 02/13/2002 | EP1178827A1 Use of antibodies identifying the interleukin-2 receptor for preventing and/or treating hiv infections |
| 02/13/2002 | EP1178826A1 Immunotherapy of b-cell malignancies using anti-cd22 antibodies |
| 02/13/2002 | EP1178824A2 Staphylococcus aureus antigen-containing whole cell vaccine |
| 02/13/2002 | EP1178821A1 Use of heparin-binding antagonists in the inhibition of bradykinin release |
| 02/13/2002 | EP1178815A1 Death domain containing receptors |
| 02/13/2002 | EP1007671B1 Fanconi-gen ii |
| 02/13/2002 | EP0866878A4 Detection of mammary tumor virus-like sequences in human breast cancer |
| 02/13/2002 | EP0866876B1 Process for the preparation of recombinant proteins in e.coli by high cell density fermentation |
| 02/13/2002 | EP0830142B1 Prrs (porcine reproductive and respiratory syndrome) virus vaccine |
| 02/13/2002 | EP0812859B1 ANTIFACTOR Xa-TISSUE FACTOR PATHWAY INHIBITOR COMPLEX MONOCLONAL ANTIBODY AND USE OF THE SAME |
| 02/13/2002 | EP0693925B1 Production of a recombinant factor xa inhibitor of leech hirudo medicinalis |
| 02/13/2002 | EP0672756B1 Monoclonal antibody recognizing fk506-binding protein, method of assaying fk506-binding protein level, and kit thereof |
| 02/13/2002 | CN1335888A OPG fusion protein compositions and methods |
| 02/13/2002 | CN1335887A Angiocidin: A Cys-Ser-Val-Thr-Cys-Gly specific tumor cell adhesion receptor |
| 02/13/2002 | CN1335884A Interluckin 17-like receptor protein |
| 02/13/2002 | CN1335324A Humanized single chain antibody of hepatitis B virus resisting preS1 antigen |
| 02/12/2002 | US6346608 MecB |
| 02/12/2002 | US6346607 A protein that induces apoptosis or binds cytochrome c; diagnosis and therapy for multiple sclerosis, parkinson's and alzheimer's diseases, cardiovascular diseases, strokes, toxin induced liver disease, cancer, lupus and herpes virus |
| 02/12/2002 | US6346606 A protein; diagnosis and therapy for tumor diseases, central nervous system diseases, glioblastomas, and breast cancer |
| 02/12/2002 | US6346517 Synergy between low molecular weight heparin and platelet aggregation inhibitors, providing a combination therapy for the prevention and treatment of various thromboembolic disorders |
| 02/12/2002 | US6346513 Internal deletion of amino acids 741 through 1668; hemophilia treatment |
| 02/12/2002 | US6346409 Tryptophenyl tRNA synthetase from Streptococcus pneumoniae |
| 02/12/2002 | US6346406 Elongation factor-2 kinase (EF-2 kinase), and methods of use therefor |
| 02/12/2002 | US6346392 Amino acid sequence from streptococcus; drug screening of bactericides and bacteriostats |
| 02/12/2002 | US6346381 Determination whether nucleotides from individual have one or more pg1-related biallelic markers or mutants; medical diagnosis |
| 02/12/2002 | US6346377 Selecting from phage display library a molecule that binds with e4 protein; detecting infection; cervical cancer prevention |
| 02/12/2002 | US6346375 NANBV diagnostics and vaccines |